StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.37−0.01 (-3.62%)

Close on Nov 18, 2026Market cap $7.20MP/E –Yield –

Ensysce Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ensysce Biosciences's total debt was $140.15K at Dec 31, 2022. For fiscal 2022 it was $140.15K, down 96.8% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$140.15K-96.8%
FY2021Dec 31, 2021$4.44M+684.2%
FY2020Dec 31, 2020$566.29K+0.0%
FY2019Dec 31, 2019$566.27K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$140.15K-96.8%
Q3 FY2022Sep 30, 2022$1.39M-34.4%
Q2 FY2022Jun 30, 2022$137.32K-75.8%
Q1 FY2022Mar 31, 2022$1.59M+180.2%
Q4 FY2021Dec 31, 2021$4.44M+684.2%
Q3 FY2021Sep 30, 2021$2.11M+273.4%
Q4 FY2020Dec 31, 2020$566.29K+0.0%
Q3 FY2020Sep 30, 2020$566.27K–
Q2 FY2020Jun 30, 2020$566.27K–
Q1 FY2020Mar 31, 2020$566.27K–
Q4 FY2019Dec 31, 2019$566.27K–

More Ensysce Biosciences figures

See a number that looks wrong?